跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法打開新的分頁/視窗

Elsevier
與我們共同出版

Evan Anderson

EA

Evan Anderson

Moderna, USA

Talk Title: RSV Prevention in Adults

Evan J. Anderson is the Executive Director, Infectious Disease Epidemiology, at Moderna. He graduated summa cum laude from Wheaton College, IL after which he pursued his medical degree at the University of Chicago Pritzker School of Medicine. He remained at the University of Chicago for residency in both internal medicine and pediatrics. Subsequently he completed a combined adult and pediatric infectious diseases fellowship at Northwestern Memorial and Children’s Memorial Hospitals in Chicago. He is board certified in internal medicine, adult infectious diseases, pediatrics and pediatric infectious diseases and split his clinical care between adults and children. He moved from Northwestern to Emory University in 2012. He served as the lead investigator in Georgia for influenza, RSV, and COVID-19 surveillance for the CDC-funded Emerging Infections Program. He was one of the multiple PIs of the Emory University Vaccine and Treatment Evaluation Unit (VTEU) and has been intricately involved with COVID-19 vaccine clinical trials in adults and children. While at Emory University School of Medicine, he rose to the rank of a full Professor of Pediatrics and Medicine. In 2023, he transitioned from Emory to a new role leading the Infectious Disease Epidemiology group at Moderna. He has over 250 total publications with particular interest in rotavirus, RSV, influenza, COVID-19, vaccine clinical trials, immunology, and epidemiology.